UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): ~~January~~May 1319, 2017 ~~(January 6, 2017)~~

SECURE POINT TECHNOLOGIES, INC.

(Exact name of Registrant as Specified in its Charter)

IMPLANT SCIENCES CORPORATION

(Former name of Registrant as Specified in its Charter)

MASSACHUSETTS

(State or Other Jurisdiction of Incorporation)


001-14949		04-2837126
(Commission File Number)		(I.R.S. Employer Identification Number)

~~c/o~~215 ~~Ellenoff~~Depot ~~Grossman~~Court ~~& Schole LLP~~SE

~~1345 Avenue of the Americas~~Leesburg, ~~11th~~Virginia ~~Floor~~20175

New York, New York 10105

(Address of Principal Executive Offices, including Zip Code)

~~500~~(212) ~~Research Drive, Unit 3~~370-1300

Wilmington, Massachusetts 01887

(Former Address of Principal Executive Offices, including Zip Code)

978-752-1700

(Registrant’s Telephone Number, including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

□ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

□ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

□ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 57.0201 ~~Departure~~Regulation ofFD ~~Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Disclosure

~~Effective~~On ~~January~~May 619, 2017, ~~Secure Point Technologies, Inc. (~~the “Company”) ~~entered~~issued ~~into~~ a ~~service~~press ~~agreement~~release (discussing the ~~“Agreement”)~~Zapata ~~with~~lawsuit ~~Christopher~~against ~~Roberts, pursuant to which Mr. Roberts agreed to assist in~~ the ~~preparation of the~~ Company’s ~~financial~~officer ~~statements~~ and ~~provide related services. In connection therewith~~director, onRobert ~~January 6, 2017, the board of directors of the Company appointed Mr~~Liscouski. ~~Roberts as the chief financial officer of the Company.~~

The ~~Agreement~~press ~~may~~release beannouncing ~~terminated~~the byZapata ~~either~~lawsuit ~~party~~is ~~upon~~attached 14hereto ~~days’~~as ~~prior~~Exhibit ~~written~~99.1 ~~notice~~and the press release is incorporated herein by this reference. The ~~Pursuant~~press torelease and the ~~Agreement,~~information Mrin Item 7.01 ~~Roberts~~of this Form 8-K shall not be andeemed ~~independent~~“filed” ~~contractor~~for purposes of Section 18 of the ~~Company~~Securities ~~and~~Exchange Act of 1934, as amended, nor shall they be ~~paid~~deemed onincorporated anby ~~hourly~~reference ~~basis~~in any filing under the Securities Act, except as shall be expressly set forth by specific reference in such filing.

Mr. Roberts has a law degree from the University of Virginia Law School and a B.S, in Electrical Engineering and an M.B.A., both from the Massachusetts Institute of Technology. The M.B.A. was concentrated in Finance and Management of Technology. He started his career working for Raytheon Co. (a Fortune 500 company). Thereafter, he practiced law at two large NYC law firms. Since leaving the private practice of law in 1983, Mr. Roberts has had several positions in finance (including as a CFO, controller and director of finance and administration) and as General Counsel. From 2010-2011, he was the CFO of Integral Systems, Inc., a public company traded on NASDAQ under the symbol “ISYS.” From 2012 to November 2016, he worked first as the CFO, and later as the President of Systems Made Simple, Inc., a wholly owned subsidiary of Leidos.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

Exhibit No.	Description	~~Description~~
10.1		Service Agreement between the Company and Chris Roberts dated January 5, 2017
99.1	Press Release of Implant Sciences Corporation, dated May 19, 2017, to announce the Zapata lawsuit against Robert Liscouski.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

~~SECURE~~IMPLANT ~~POINT~~SCIENCES ~~TECHNOLOGIES, INC.~~CORPORATION

By: /s/ Robert P. Liscouski

Name: Robert P. Liscouski

Title: President and Chief Executive Officer

Date: ~~January~~May 1319, 2017

EXHIBIT INDEX



Exhibit No.	Description

99.1	Press Release of Implant Sciences Corporation, dated May 19, 2017 to announce the Zapata lawsuit against Robert Liscouski.

Filing Compare · SECURE POINT TECHNOLOGIES INC